PL BioScience
The company develops and manufactures Human Platelet Lysate (HPL) products under the ELAREM™ brand as a xeno-free alternative to Fetal Bovine Serum. Their technology reprocesses human platelets into nutrient-rich supplements for 2D and 3D cell culture, including specialized hydrogels and virus-inactivated solutions. These products serve academic research, diagnostics, and the development of regenerative stem cell therapies and clinical applications.
Visit websiteAachen, Germany
Biotechnology
Life Sciences
Regenerative Medicine
Healthtech
Funding summary
- Total raised
- €7.8M
- Funding rounds
- 1
Investors in PL BioScience
Investors on record for PL BioScience. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like PL BioScience?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors